AstraZeneca Says Obesity Pill Shows Minimal Side Effects in Early Trial
The Anglo-Swedish drugmaker’s closely watched weight loss pill, AZD5004, was well tolerated by patients in an early-stage ...
Medscape6 天
Possible Dose-Side Effect Relationship of Antipsychotic Drugs: Relevance to Cognitive ...
The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to induce neurologic side effects compared with typical (conventional) antipsychotics ...
pharmaphorum2 天
Boehringer, Lilly’s Jardiance tries to match AZ’s Farxiga with heart failure label
helped by side-effect problems that have afflicted first-to-market rival Invokana (canagliflozin) from Johnson & Johnson. However its rivals – which also include AstraZeneca’s Farxiga ...
AZFamily5 天
On Your Side
The Arizona Attorney General’s Office settled with a shutter and blind company accused of scamming clients and not returning their money.
The Pharma Letter1 天
AstraZeneca sees progress in obesity drug trials, highlights new oral option
AstraZeneca showcased positive early data on three experimental weight-loss drugs at ObesityWeek, highlighting its oral GLP-1 ...
AOL2 天
4 Ways to Prevent Muscle Loss on Ozempic & Other Weight Loss GLP-1 Medications
You might be familiar with the drug’s digestive side effects, like nausea and diarrhea ... This includes canagliflozin ...
pharmaphorum1 天
ESC22: Despite trial misses, Bayer preps phase 3 for asundexian
The promise of the new class is that inhibiting Factor XIa seems to provide the same anticoagulant properties of current anticoagulants, without raising the risk of bleeding side effects.
heise online6 天
Windows update side effect: Weakness in counting in the task manager
The Windows Update Preview appeared last week. It does not appear to have any serious side effects, but introduces a bizarre error under Windows 11 24H2: The task ...